These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17074639)

  • 1. Safe and effective conversion of persistent atrial fibrillation to sinus rhythm by intravenous AZD7009.
    Crijns HJ; Van Gelder IC; Walfridsson H; Kulakowski P; Rónaszéki A; Dedek V; Malm A; Almgren O
    Heart Rhythm; 2006 Nov; 3(11):1321-31. PubMed ID: 17074639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid conversion of persistent atrial fibrillation to sinus rhythm by intravenous AZD7009.
    Geller JC; Egstrup K; Kulakowski P; Rosenqvist M; Jansson MA; Berggren A; Edvardsson N; Sager P; Crijns HJ
    J Clin Pharmacol; 2009 Mar; 49(3):312-22. PubMed ID: 19129422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid slowing of the atrial fibrillatory rate after administration of AZD7009 predicts conversion of atrial fibrillation.
    Aunes M; Egstrup K; Frison L; Berggren A; Stridh M; Sörnmo L; Edvardsson N
    J Electrocardiol; 2014; 47(3):316-23. PubMed ID: 24508473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse Correlation between the Atrial Fibrillatory Rate and the Ventricular Repolarization Time: Observations at Baseline and after an Intravenous Infusion of a Combined Potassium and Sodium Current Blocker.
    Edvardsson N; Aunes M; Frison L; Berggren AR
    Ann Noninvasive Electrocardiol; 2016 May; 21(3):236-45. PubMed ID: 26246430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter, open-label study of vernakalant for the conversion of atrial fibrillation to sinus rhythm.
    Stiell IG; Roos JS; Kavanagh KM; Dickinson G
    Am Heart J; 2010 Jun; 159(6):1095-101. PubMed ID: 20569725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of vernakalant for the conversion of atrial fibrillation to sinus rhythm; a phase 3b randomized controlled trial.
    Beatch GN; Mangal B
    BMC Cardiovasc Disord; 2016 May; 16():113. PubMed ID: 27233239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of a single oral dose of vanoxerine for the conversion of subjects with recent onset atrial fibrillation or flutter to normal sinus rhythm: RESTORE SR.
    Piccini JP; Pritchett EL; Davison BA; Cotter G; Wiener LE; Koch G; Feld G; Waldo A; van Gelder IC; Camm AJ; Kowey PR; Iwashita J; Dittrich HC
    Heart Rhythm; 2016 Sep; 13(9):1777-83. PubMed ID: 27108936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COR-ART: A multicenter, randomized, double-blind, placebo-controlled dose-ranging study to evaluate single oral doses of vanoxerine for conversion of recent-onset atrial fibrillation or flutter to normal sinus rhythm.
    Dittrich HC; Feld GK; Bahnson TD; Camm AJ; Golitsyn S; Katz A; Koontz JI; Kowey PR; Waldo AL; Brown AM
    Heart Rhythm; 2015 Jun; 12(6):1105-12. PubMed ID: 25684233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial.
    Kowey PR; Dorian P; Mitchell LB; Pratt CM; Roy D; Schwartz PJ; Sadowski J; Sobczyk D; Bochenek A; Toft E;
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):652-9. PubMed ID: 19948506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exaggerated QT prolongation after cardioversion of atrial fibrillation.
    Choy AM; Darbar D; Dell'Orto S; Roden DM
    J Am Coll Cardiol; 1999 Aug; 34(2):396-401. PubMed ID: 10440151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled trial. Danish Dofetilide in Atrial Fibrillation and Flutter Study Group.
    Nørgaard BL; Wachtell K; Christensen PD; Madsen B; Johansen JB; Christiansen EH; Graff O; Simonsen EH
    Am Heart J; 1999 Jun; 137(6):1062-9. PubMed ID: 10347332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Conversion rate and prevention of recurrence of paroxysmal and sustained atrial fibrillation or atrial flutter with verapamil/quinidine].
    Trappe HJ; Pfitzner P
    Med Klin (Munich); 1996 Oct; 91(10):617-25. PubMed ID: 9019638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study.
    Ellenbogen KA; Stambler BS; Wood MA; Sager PT; Wesley RC; Meissner MC; Zoble RG; Wakefield LK; Perry KT; Vanderlugt JT
    J Am Coll Cardiol; 1996 Jul; 28(1):130-6. PubMed ID: 8752805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological cardioversion of atrial fibrillation--a double-blind, randomized, placebo-controlled, multicentre, dose-escalation study of AZD1305 given intravenously.
    Rónaszéki A; Alings M; Egstrup K; Gaciong Z; Hranai M; Király C; Sereg M; Figatowski W; Bondarov P; Johansson S; Frison L; Edvardsson N; Berggren A
    Europace; 2011 Aug; 13(8):1148-56. PubMed ID: 21561900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of vernakalant hydrochloride injection for rapid conversion of atrial fibrillation.
    Pratt CM; Roy D; Torp-Pedersen C; Wyse DG; Toft E; Juul-Moller S; Retyk E; Drenning DH;
    Am J Cardiol; 2010 Nov; 106(9):1277-83. PubMed ID: 21029824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ibutilide: efficacy and safety in atrial fibrillation and atrial flutter in a general cardiology practice.
    Eversole A; Hancock W; Johns T; Lopez LM; Conti CR
    Clin Cardiol; 2001 Jul; 24(7):521-5. PubMed ID: 11444644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators.
    Stambler BS; Wood MA; Ellenbogen KA; Perry KT; Wakefield LK; VanderLugt JT
    Circulation; 1996 Oct; 94(7):1613-21. PubMed ID: 8840852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vernakalant hydrochloride: A novel atrial-selective agent for the cardioversion of recent-onset atrial fibrillation in the emergency department.
    Stiell IG; Dickinson G; Butterfield NN; Clement CM; Perry JJ; Vaillancourt C; Calder LA
    Acad Emerg Med; 2010 Nov; 17(11):1175-82. PubMed ID: 21175515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of amiodarone versus bepridil in achieving conversion to sinus rhythm in patients with persistent atrial fibrillation: a randomised trial.
    Yamase M; Nakazato Y; Daida H
    Heart; 2012 Jul; 98(14):1067-71. PubMed ID: 22689712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous propafenone: efficacy and safety in the conversion to sinus rhythm of recent onset atrial fibrillation--a single-blind placebo-controlled study.
    Bellandi F; Dabizzi RP; Cantini F; Natale MD; Niccoli L
    Cardiovasc Drugs Ther; 1996 May; 10(2):153-7. PubMed ID: 8842507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.